Physician profile
Elena Geller
NPI 1053579425
$4,606.39
in general payments reported to CMS, 2019-2025
20 companies · $852 in 2025
The $852 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $15.38 · 2022: $49.32 · 2023: $2,581 · 2024: $952 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548 · Honoraria: $1,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.82 |
| Honoraria | $1,837.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,071.01 | 2022-2023 | Tepezza |
| Alcon Vision LLC | $693.15 | 2023-2025 | Clareon, Centurion, Rocklatan |
| Bausch & Lomb Americas INC. | $472.40 | 2023-2025 | Envista Mx60 Iol, Xiidra, Amvisc |
| Mallinckrodt Hospital Products INC. | $301.41 | 2024-2025 | Acthar |
| Amgen INC. | $241.98 | 2024-2025 | Tepezza |
| Carl Zeiss Meditec Cataract Technology INC. | $192.37 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $108.07 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $104.24 | 2023-2024 | Tecnis Simplicity, Tecnis Iol |
| Abbvie INC. | $63.25 | 2024 | |
| Biotissue Holdings INC. | $41.49 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $35.33 | 2023-2025 | Cequa |
| Allergan, INC. | $31.37 | 2019 | |
| Dompe US, INC. | $24.76 | 2025 | Oxervate |
| Halozyme INC | $23.48 | 2024 | Hylenex Recombinant |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $18.16 | 2025 | Dextenza |
| Kala Pharmaceuticals, INC. | $16.67 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.38 | 2020 | |
| Sight Sciences, INC. | $14.27 | 2023 | Omni Surgical System |
| Oyster Point Pharma, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Geller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.